HNRNPA2B1 and neoplasm: Taken together, these results provided comprehensive evidence that hnRNPA2B1 could significantly contribute to the tumor growth and metastasis of CRC cells in vitro and in vivo, which suggested that hnRNPA2B1 was a clinically crucial oncogene in CRC.